OAKLEY CAPITAL INV.LS-01
Oakley Capital Investments Limited is a private equity and venture capital firm specializing in investments in early stage, series B, growth capital, later stage, emerging growth, mid-markets, corporate carve-outs, buyouts, mezzanine, restructuring, management buy-outs, management buy-ins, small-mid buyout, public to privates, re-financings, secondary purchases, turnarounds, industry consolidatio… Read more
OAKLEY CAPITAL INV.LS-01 (34O) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, OAKLEY CAPITAL INV.LS-01 (34O) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
OAKLEY CAPITAL INV.LS-01 - Net Assets Trend (None–None)
This chart illustrates how OAKLEY CAPITAL INV.LS-01's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for OAKLEY CAPITAL INV.LS-01 (None–None)
The table below shows the annual net assets of OAKLEY CAPITAL INV.LS-01 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to OAKLEY CAPITAL INV.LS-01's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
OAKLEY CAPITAL INV.LS-01 Competitors by Market Cap
The table below lists competitors of OAKLEY CAPITAL INV.LS-01 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Dynavox Group
ST:DYVOX
|
$786.85 Million |
|
Biotage AB
ST:BIOT
|
$787.18 Million |
|
Stanley Fertilizer Co Ltd
SHE:002588
|
$787.44 Million |
|
Suzhou Jinfu New Material Co
SHE:300128
|
$787.52 Million |
|
Cementos Pacasmayo S.A.A
F:EPCC
|
$786.60 Million |
|
iShares MSCI
OTCGREY:ISRMF
|
$786.47 Million |
|
Xinhua Winshare Publishing and Media Co Ltd
SHG:601811
|
$786.34 Million |
|
Viridien Société anonyme
F:GDG
|
$786.17 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in OAKLEY CAPITAL INV.LS-01's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares OAKLEY CAPITAL INV.LS-01's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently OAKLEY CAPITAL INV.LS-01 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares OAKLEY CAPITAL INV.LS-01's net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| OAKLEY CAPITAL INV.LS-01 (34O) | €- | N/A | N/A | $786.64 Million |
| Hanna Capital Corp (04U1) | $-79.29K | 0.00% | 0.00x | $116.52K |
| WESTMINSTER RES (08W) | $4.66 Million | -31.33% | 0.12x | $5.16 Million |
| Axonics Inc (0I3) | $570.14 Million | -10.47% | 0.16x | $3.29 Billion |
| Global Bioenergies SA (1DK) | $14.81 Million | -86.04% | 0.89x | $369.68K |
| GIEAG Immobilien AG (2GI) | $41.80 Million | 40.21% | 8.93x | $15.57K |
| 2invest AG (2INV) | $82.61 Million | -2.29% | 0.06x | $13.67 Million |
| PT Central Proteina Prima Tbk (4PT) | $3.42 Trillion | 11.74% | 1.00x | $6.90 Million |
| DGH Deutsche Grundwert Holding AG (5TR) | $0.00 | 0.00% | 0.00x | $18.45K |
| SOFTCHOICE CORP. (90Q) | $58.23 Million | -19.76% | 10.01x | $470.36 Million |
| ALBA SE (ABA) | $142.95 Million | 5.25% | 0.45x | $5.10 Million |